findmyKOL

Kenneth Bilchick, MD

Enriched profile

Professor of Medicine, Cardiovascular Medicine · University of Virginia Health System

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Charlottesville, VA · Southeast · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusCardiac pacing and defibrillation studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2009–2024

Kenneth Bilchick is Professor of Medicine, Cardiovascular Medicine at University of Virginia Health System. OpenAlex indexes 377 publications with 4,816 citations (h-index 35); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Kenneth Bilchick, M.D., is Professor of Medicine, Cardiovascular Medicine at University of Virginia Health System. The public record shows 377 publications with 4,816 citations (h-index 35), centered on Cardiac pacing and defibrillation studies, Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 3 companies, 6 NIH-funded awards (2009–2024).

  • Most recent indexed publication: 2026 · Journal of geriatric neurology
  • Top research focus: Cardiac pacing and defibrillation studies
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure4 trialsHeart Failure, Systolic3 trialsAtrial Fibrillation1 trialPica1 trialBradycardia1 trialVentricular Dysfunction1 trial

Research focus

OpenAlex concept fingerprint
Cardiac pacing and defibrillation studiesCardiac Imaging and DiagnosticsCardiovascular Function and Risk FactorsCardiac electrophysiology and arrhythmiasHeart Failure Treatment and Management

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments46Boston Scientific CorporationClinical trials—Industry payments11Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments6University of VirginiaClinical trials2Industry payments—Imricor Medical SystemsClinical trials1Industry payments—Kenneth Bilchick, MDClinical trials1Industry payments—VDI TechnologiesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
377publications

Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.

4,816citations

Total citations across indexed works.

35h-index

Hirsch index (OpenAlex). i10-index 67.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 2009–2024

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    64%
    Beta blocker24.2%
    Metoprolol Succinate79%Carvedilol10%Sotalol8%Metoprolol Tartrate3%
    Part D<11 patients
    Antiarrhythmic13.8%
    Flecainide Acetate35%Amiodarone Hcl34%Multaq17%Dofetilide14%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    27.3%
    Factor Xa inhibitor26.5%
    Eliquis83%Xarelto17%
    Part D≥89 patients
    P2Y12 inhibitor0.8%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.6%
    SGLT2 inhibitor2.6%
    Jardiance67%Farxiga33%
    Part D<11 patients
    Proton pump inhibitor1.2%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 1 more class in this area

All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)66.5% facility · 33.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

6 NIH research awards on record, funded 2009–2024 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Sula Mazimba137Younghoon Kwon57Frederick H. Epstein57Khadijah K Breathett49Pamela Kay Mason42Stefan Richard Bornstein42Zoran Gatalica42Marcia Spinelli Casanova42Mario Vaccaro42Richard F. Ambinder42Oladapo Adedamola Adewuya42William Lane M. Robson42Dieter Metze42Ferid Murad42Claudio Guarneri41Kunihiko Suzuki39Christopher M. Kramer36Jamie L.W. Kennedy36Rohit Malhotra36Nishaki Kiran Mehta33Derek J. Bivona32S. Diane Hayward31Michael Salerno31James Michael Mangrum31Khalid Hussain27James D. Bergin26Alexander K. C. Leung25John Ferguson25Mohammad Abuannadi24Nishaki M Mehta23Alexander K. C. Leung23Hunter Mwansa21Andrew D. Mihalek21Patrick L. Stafford21John Dimarco20Amit R. Patel17Nicholas Ashur17Olivia Ondigi16Mohamad Abdi15Nishtha Sodhi15

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/kenneth-bilchick-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chair

    Heart Rhythm Society Research Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
  • Chair

    Society for Cardiovascular Magnetic Resonance Research Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
  • Member

    ACC/NCDR Research and Publications Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.